TriSalus Life Sciences, Inc.
TLSI
$4.20
$0.122.94%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.75M | -10.81M | -8.29M | -10.38M | -10.11M |
| Total Depreciation and Amortization | 126.00K | 163.00K | 165.00K | 172.00K | 193.00K |
| Total Amortization of Deferred Charges | 282.00K | 275.00K | 257.00K | 235.00K | 178.00K |
| Total Other Non-Cash Items | 7.39M | 4.28M | 1.93M | 3.87M | 3.56M |
| Change in Net Operating Assets | -530.00K | 2.39M | -1.39M | 1.60M | 467.00K |
| Cash from Operations | -2.48M | -3.71M | -7.32M | -4.50M | -5.71M |
| Capital Expenditure | -41.00K | -216.00K | 93.00K | -754.00K | -50.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 40.00K | 0.00 | 40.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -41.00K | -176.00K | 93.00K | -714.00K | -50.00K |
| Total Debt Issued | 0.00 | 0.00 | 0.00 | 10.00M | 0.00 |
| Total Debt Repaid | -3.00K | -6.00K | -1.00K | -71.00K | -19.00K |
| Issuance of Common Stock | 280.00K | 88.00K | 22.27M | 279.00K | 3.01M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -1.55M | -520.00K | 0.00 |
| Cash from Financing | 277.00K | 82.00K | 20.72M | 9.69M | 2.99M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.25M | -3.80M | 13.49M | 4.48M | -2.76M |